InterventionsReview
Glucagon‐like peptide‐1 receptor agonists for neurological disorders: a systematic review and meta‐analysis
AAIC 2025 Abstract
Abstract
Background: Glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) are currently approved for type 2 diabetes mellitus, obesity, and obstructive sleep apnea.
